Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...

BEIJING, Aug. 21, 2026 /PRNewswire/ -- Personalized mRNA cancer therapy has recently reached an important milestone. An international Phase 3 study in high-risk melanoma reported positive results, ...

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at ...

Oct 2 (Reuters) - Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine — which relies on the ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Speaker 1: From the opinion pages of the Wall Street Journal, this is Potomac ...

The European Medicines Agency just approved a new Moderna mRNA flu vaccine—after clinical data demonstrated strong protection for older adults. In the United States, the same technology is facing a ...